A Phase 1, Open Label, Fixed Sequence Study To Investigate The Effect Of Multiple Doses Of PF-04531083 On Simvastatin And Simvastatin Acid Pharmacokinetics Following Single Dose Of Simvastatin in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 03 Jun 2010
At a glance
- Drugs PF 4531083; Simvastatin
- Indications Diabetic cardiomyopathy; Hypercholesterolaemia; Hyperlipoproteinaemias; Hypertriglyceridaemia; Lipid metabolism disorders; Multiple sclerosis; Pain
- Focus Pharmacokinetics
- Sponsors Pfizer
- 03 Jun 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 03 Jun 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2010 New trial record